Barclays has initiated coverage on Doximity Inc (DOCS) with an Overweight rating as of December 8, 2025. This marks the firm's first assessment of the company's investment potential. Doximity, headquartered in San Francisco, operates an online platform for medical professionals, offering marketing, hiring, and workflow solutions tailored for the healthcare industry. The company, which went public on June 24, 2021, currently has a market cap of $10.2 billion and a P/E ratio of 43.25, with an EPS of 1.16.
Analysts have a consensus rating of Buy for Doximity, with 9 Strong Buy, 7 Buy, 9 Hold, 2 Sell, and no Strong Sell ratings among 27 total ratings as of December 1, 2025. Upcoming earnings reports are expected on May 13, 2026, and August 5, 2026, with estimated EPS of $0.33 and $0.37, respectively.
Analyst ratings provide a professional perspective based on research and financial modeling, but they should be one of many factors considered in investment decisions. Ratings can change as new information emerges, reflecting the dynamic nature of market analysis.